Cerebrolysin is a hydrolysate of a porcine brain which is used as a nootropic drug.
Cerebrolysin was discovered in 1949 in Austria and is used in medical practice since 1954. The drug has a broad range of indications including ischemic stroke, Alzheimer’s, Parkinson’s, dementia, traumatic brain injury, and ADHD in children.
The chemical composition of Cerebrolysin is pretty complex and consists of various neuropeptides, amino acids, and neurotrophic factors. One of the most important advantages of Cerebrolysin is its high tolerability in patients, as it rarely causes any side effects, high efficacy, and a wide spectrum of therapeutic action.
The official indications for use are:
- Chronic cerebrovascular insufficiency
- Ischemic stroke
- Alzheimer’s disease
- Dementia
- Traumatic injuries of brain and spinal cord
- Developmental delays in children
- Attention deficit hyperactivity disorder in children
- Antidepressant resistant depression